Diagnostics
News and analysis on diagnostic technologies and applications.
NeoGenomics Q4 Revenues up 11 Percent, Miss Analyst Estimates
Fourth quarter revenues of $172 million fell short of analysts' average expectations, but the company saw a boost in volume and average billing driven by a push toward higher-value tests.
ClearNote Health Gains NYS DOH Clearance for Pancreatic Cancer Blood Test
The liquid biopsy test quantitatively measures 5-hydroxymethylcytosine in cell-free DNA, and combines this data with other genomic information for early disease detection.
T2 Biosystems Lays off Employees, Inks Consulting Agreements With Top Execs
Following a delisting decision by the Nasdaq Hearings Panel, the firm laid off its workforce and agreed to pay top executives for part-time consulting work.
Foundation Medicine, Sumitomo Pharma to Develop CDx for Acute Leukemia Treatment
The companies will use the FoundationOne Heme platform to identify patients with acute leukemia who have a KMT2A rearrangement or NPM1 mutations.
GeneDx Q4 Revenues Climb 64 Percent, Bolstered by Strong Clinical Testing Business
The genetic testing firm booked $95.3 million in Q4 revenues, while full-year 2024 revenues were up 51 percent to $305.5 million.